GGrantScoutHQFind grants
← Back to grants

Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on novel therapies for adult glioblastoma (GBM). The goal is to improve the treatment of adult GBM by developing novel effective agents that can cross the blood brain barrier (BB

Funding
Estimated total program funding: $4,400,000
Category
Health & Medical
Status
OPEN
Deadline
10/2/2026

About

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on novel therapies for adult glioblastoma (GBM). The goal is to improve the treatment of adult GBM by developing novel effective agents that can cross the blood brain barrier (BBB) and testing them clinically. Successful early-stage trials of new drugs from this NOFO would transition seamlessly to later stage trials using well-established NCI clinical trial mechanisms.To implement this concept, a highly collaborative GBM Therapeutics Network (GTN) of cross-cutting teams will be established, each team capable of driving therapeutic agent(s) from pre-clinical development, through investigational new drugs (IND) studies, into pilot clinical studies in humans. Appropriate therapeutic agents include: (1) novel agents or (2) agents or combinations approved for other indications and repurposed for treatment of GBM following appropriate preclinical studies. The scope of the NOFO, from late pre-clinical through early (Phase 0/1) clinical studies, uniquely spans a gap in the GBM drug development process.

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Applicant types

Grants.gov eligibility code 00Grants.gov eligibility code 01Grants.gov eligibility code 02Grants.gov eligibility code 04Grants.gov eligibility code 05Grants.gov eligibility code 06Grants.gov eligibility code 07Grants.gov eligibility code 08Grants.gov eligibility code 11Grants.gov eligibility code 12Grants.gov eligibility code 13Grants.gov eligibility code 20Grants.gov eligibility code 22Grants.gov eligibility code 23Grants.gov eligibility code 25
Visit Official Funding Page →

Continue researching

Related current grants

All Health & Medical grants →

Medical Student Education Program (MSE)

Health Resources and Services Administration

The Medical Student Education (MSE) Program provides support to public medical schools in the top quartile of states with a projected primary care provider shortage to expand or support education for medical students preparing to become physicians.

NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)

National Institutes of Health

The NIH Director"s Transformative Research Award supports individual scientists or groups of scientists proposing bold, groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved c

Addressing Dementia in Tribal and Urban Indian Communities: CAReS Program

Indian Health Service

This program is intended to support Tribal and Urban Indian communities in strengthening dementia care and services for American Indian and Alaska Native (AI/AN) people. Rooted in Indigenous values and community self-determination, the program will fund meaningful, measurable improvements that span

Applied Drug Policy Research Experiences

Office of National Drug Control Policy

This project will establish applied drug policy research experiences for graduate students and recent post-graduates to conduct rigorous research studies and data analyses to support the National Drug Control Strategy. This research will investigate dynamic shifts in, and associations between, illic

Notice-specific evidence check

What an applicant must verify for Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

Applicant evidence

  • Applicant type: Grants.gov eligibility code 00
  • Applicant type: Grants.gov eligibility code 01
  • Applicant type: Grants.gov eligibility code 02
  • Applicant type: Grants.gov eligibility code 04
  • Applicant type: Grants.gov eligibility code 05
  • Applicant type: Grants.gov eligibility code 06
  • Applicant type: Grants.gov eligibility code 07
  • Applicant type: Grants.gov eligibility code 08

Opportunity boundaries

  • Recorded funding: Estimated total program funding: $4,400,000
  • Recorded deadline: October 2, 2026; confirm time zone and submission system.
  • Recorded focus: Health
Before investing in an application, connect every eligibility claim, required registration, submission component and deadline to the current official notice. Open the recorded official source →